Astilbin ameliorates oxidative stress and apoptosis in D-galactose-induced senescence by regulating the PI3K/Akt/m-TOR signaling pathway in the brains of mice

Yue Zhang,Chuanbo Ding,Yuan Cai,Xueyan Chen,Yingchun Zhao,Xinglong Liu,Jinping Zhang,Shunwen Sun,Wencong Liu

DOI: https://doi.org/10.1016/j.intimp.2021.108035

IF: 5.714

2021-10-01

International Immunopharmacology

Abstract:An increasing amount of evidence has shown that injection of D-galactose (D-gal) can mimic natural aging that typically is associated with brain injury. Oxidative stress and apoptosis has been shown to play an essential role in aging process. The purpose of this study was to investigate the protective effects of astilbin (ASB) on D-Gal-induced aging in mice and to further explore the underlying mechanisms. We randomly divided 50 mice into 5 groups. To establish this model of aging, 40 mice were intraperitoneally administered D-Gal (500 mg/kg). The mice in the treatment groups were intragastricaly administrated ASB at doses of 40 and 80 mg/kg. H&E and TUNEL staining were used to determine the effect of ASB on the number of apoptotic cells in the brain. Furthermore, biochemical indices of serum, oxidative stress factors, and apoptosis factors were determined to clarify the underlying mechanism using reagent test kits and western blotting. The results showed that varying doses of ASB could improve D-Gal-induced histopathological damage and significantly alleviated the aging induced by D-Gal in mice. ASB remarkably decreased the activities of malondialdehyde (MDA) (p < 0.01) and Acetyl cholinesterase (AChE) (p < 0.05) and markedly increased the content of catalase (CAT) (p < 0.01) and superoxide dismutase (SOD) (p < 0.01), respectively. In addition, Western blotting revealed that ASB treatment (40 mg/kg) attenuated the D-gal-induced Bax and Caspase 3 protein expression (p < 0.01) and reversed the increase in Bcl-2 protein expression in brain. Moreover, ASB treatment significantly upregulated the protein expression of p-PI3K/PI3K and altered the p-Akt/Akt ratio (p < 0.05), while inhibiting the expression of p-m-TOR relative to m-TOR (p < 0.05). Moreover, the expression of P53 tended to decrease in the low ASB treatment group (40 mg/kg), whereas no change was observed in the high ASB treatment group (80 mg/kg). In the intestinal flora, the richness of the normal group and the ASB group was higher than that of the D-Gal group. Heat map analysis also showed that ASB promoted Lactobacillus and other probiotics and also confirmed the advantages of ASB. The observed changes in intestinal flora further verified the efficacy of ASB.

pharmacology & pharmacy,immunology